{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:47:23Z","timestamp":1780058843351,"version":"3.54.0"},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["GOA no. 10\/014"],"award-info":[{"award-number":["GOA no. 10\/014"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21172019"],"award-info":[{"award-number":["21172019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2019,10,14]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Clinical drugs for herpesvirus exhibit high toxicity and suffer from significant\ndrug resistance. The development of new, effective, and safe anti-herpesvirus agents with\ndifferent mechanisms of action is greatly required.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Novel inhibitors against herpesvirus with different mechanisms of action from that of\nclinical drugs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> A series of novel 5-(benzylamino)-1H-1,2,3-triazole-4-carboxamides were efficiently\nsynthesized and EC50 values against Human Cytomegalovirus (HCMV), Varicella-Zoster Virus\n(VZV) and Herpes Simplex Virus (HSV) were evaluated in vitro.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Some compounds present antiviral activity. Compounds 5s and 5t are potent against both\nHCMV and VZV. Compounds 5m, 5n, 5s, and 5t show similar EC50 values against both TK+ and\nTK\u2212 VZV strains.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>5-(Benzylamino)-1H-1, 2,3-triazole-4-carboxamides are active against herpesviruses\nand their activity is remarkably affected by the nature and the position of substituents in the benzene\nring. The results indicate that these derivatives are independent of the viral thymidine kinase\n(TK) for activation, which is indispensable for current drugs. Their mechanisms of action may differ\nfrom those of the clinic anti-herpesvirus drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406414666181109095239","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T07:22:08Z","timestamp":1541748128000},"page":"801-812","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Synthesis, Anti-Varicella-Zoster Virus and Anti-Cytomegalovirus Activity of 4,5-Disubstituted 1,2,3-(1H)-Triazoles"],"prefix":"10.2174","volume":"15","author":[{"given":"Wei-yuan","family":"Yuan","sequence":"first","affiliation":[{"name":"School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-ning","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ning","family":"Wen","sequence":"additional","affiliation":[{"name":"School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[{"name":"Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, Leuven B-3000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[{"name":"Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, Leuven B-3000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hong","family":"Xiang","sequence":"additional","affiliation":[{"name":"School of Chemistry, Capital Normal University, Beijing 100048, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-wei","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[{"name":"Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, Leuven B-3000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-yong","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Chemistry, Capital Normal University, Beijing 100048, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-pei","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1021\/cr500255e","volume":"114","author":"Gable J.E.","year":"2014","unstructured":"Gable J.E.; Acker T.M.; Craik C.S.; Current and potential treatments for ubiquitous but neglected herpesvirus infections. Chem Rev 2014,114,11382-11412","journal-title":"Chem Rev"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/AAC.41.12.2680","volume":"41","author":"Tenney D.J.","year":"1997","unstructured":"Tenney D.J.; Yamanaka G.; Voss S.M.; Cianci C.W.; Tuomari A.V.; Sheaffer A.K.; Alam M.; Colonno R.J.; lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase. Antimicrob Agent Chemother 1997,41,2680-2685","journal-title":"Antimicrob Agent Chemother"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/ldt011","volume":"106","author":"Field H.J.","year":"2013","unstructured":"Field H.J.; Vere Hodge R.A.; Recent developments in anti-herpesvirus drugs. Br Med Bull 2013,106,213-249","journal-title":"Br Med Bull"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-405880-4.00004-4","volume":"67","author":"Andrei G.","year":"2013","unstructured":"Andrei G.; Snoeck R.; Advances in the treatment of varicella-zoster virus infections. Adv Pharmacol 2013,67,107-168","journal-title":"Adv Pharmacol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/TP.0b013e3181cee42f","volume":"89","author":"Kotton C.N.","year":"2010","unstructured":"Kotton C.N.; Kumar D.; Caliendo A.M.; Asberg A.; Chou S.; Snydman D.R.; Allen U.; Humar A.; Transplantat Soc Int, C.M.V.C. International consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2010,89,779-795","journal-title":"Transplantation"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","volume":"96","author":"Kotton C.N.","year":"2013","unstructured":"Kotton C.N.; Kumar D.; Caliendo A.M.; Asberg A.; Chou S.; Danziger-Isakov L.; Humar A.; Transplantat Soc Int, C.M.V. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013,96,333-360","journal-title":"Transplantation"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/187152609787847758","volume":"9","author":"Andrei G.","year":"2009","unstructured":"Andrei G.; De Clercq E.; Snoeck R.; Drug targets in cytomegalovirus infection. Infect Disord Drug Targets 2009,9,201-222","journal-title":"Infect Disord Drug Targets"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","volume":"23","author":"Lurain N.S.","year":"2010","unstructured":"Lurain N.S.; Chou S.; Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 2010,23,689-712","journal-title":"Clin Microbiol Rev"},{"key":"ref=9","first-page":"269","volume":"8","author":"Melendez D.P.","year":"2015","unstructured":"Melendez D.P.; Razonable R.R.; Letermovir and inhibitors of the terminase complex: A promising new class of investigational antiviral drugs against human cytomegalovirus. Infect Drug Resist 2015,8,269-277","journal-title":"Infect Drug Resist"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/AAC.05908-11","volume":"56","author":"Marschall M.","year":"2012","unstructured":"Marschall M.; Stamminger T.; Urban A.; Wildum S.; Ruebsamen-Schaeff H.; Zimmermann H.; Lischka P.; \n                        In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (Letermovir) against herpesviruses and other human pathogenic viruses. Antimicrob Agents Chemother 2012,56,1135-1137","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1600-6143.2011.03530.x","volume":"11","author":"Kaul D.R.","year":"2011","unstructured":"Kaul D.R.; Stoelben S.; Cober E.; Ojo T.; Sandusky E.; Lischka P.; Zimmermann H.; Rubsamen-Schaeff H.; First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246. Am J Transplant 2011,11,1079-1084","journal-title":"Am J Transplant"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0402-386","volume":"8","author":"Crute J.J.","year":"2002","unstructured":"Crute J.J.; Grygon C.A.; Hargrave K.D.; Simoneau B.; Faucher A.M.; Bolger G.; Kibler P.; Liuzzi M.; Cordingley M.G.; Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease. Nat Med 2002,8,386-391","journal-title":"Nat Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm0402-392","volume":"8","author":"Kleymann G.","year":"2002","unstructured":"Kleymann G.; Fischer R.; Betz U.A.K.; Hendrix M.; Bender W.; Schneider U.; Handke G.; Eckenberg P.; Hewlett G.; Pevzner V.; Baumeister J.; Weber O.; Henninger K.; Keldenich J.; Jensen A.; Kolb J.; Bach U.; Popp A.; Maben J.; Frappa I.; Haebich D.; Lockhoff O.; Rubsamen-Waigmann H.; New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat Med 2002,8,392-398","journal-title":"Nat Med"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMoa1301150","volume":"370","author":"Wald A.","year":"2014","unstructured":"Wald A.; Corey L.; Timmler B.; Magaret A.; Warren T.; Tyring S.; Johnston C.; Kriesel J.; Fife K.; Galitz L.; Stoelben S.; Huang M-L.; Selke S.; Stobernack H-P.; Ruebsamen-Schaeff H.; Birkmann A.; Helicase-primase inhibitor pritelivir for HSV-2 infection. Eng J Med 2014,370,201-210","journal-title":"Eng J Med"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/48.6.757","volume":"48","author":"Reefschlaeger J.","year":"2001","unstructured":"Reefschlaeger J.; Bender W.; Hallenberger S.; Weber O.; Eckenberg P.; Goldmann S.; Haerter M.; Buerger I.; Trappe J.; Herrington J.A.; Haebich D.; Ruebsamen-Waigmann H.; Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): In vitro and in vivo antiviral activity and mechanism of action. J Antimicrob Chemother 2001,48,757-767","journal-title":"J Antimicrob Chemother"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.48.5.1647-1651.2004","volume":"48","author":"Underwood M.R.","year":"2004","unstructured":"Underwood M.R.; Ferris R.G.; Selleseth D.W.; Davis M.G.; Drach J.C.; Townsend L.B.; Biron K.K.; Boyd F.L.; Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus. Antimicrob Agents Chemother 2004,48,1647-1651","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1021\/jm970104t","volume":"40","author":"Ogilvie W.","year":"1997","unstructured":"Ogilvie W.; Bailey M.; Poupart M.A.; Abraham A.; Bhavsar A.; Bonneau P.; Bordeleau J.; Bousquet Y.; Chabot C.; Duceppe J.S.; Fazal G.; Goulet S.; Grandmaitre C.; Guse I.; Halmos T.; Lavallee P.; Leach M.; Malenfant E.; Omeara J.; Plante R.; Plouffe C.; Poirier M.; Soucy F.; Yoakim C.; Deziel R.; Peptidomimetic inhibitors of the human cytomegalovirus protease. J Med Chem 1997,40,4113-4135","journal-title":"J Med Chem"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1016\/S0960-894X(03)00789-3","volume":"13","author":"Di Grandi M.J.","year":"2003","unstructured":"Di Grandi M.J.; Curran K.J.; Baum E.Z.; Bebernitz G.; Ellestad G.A.; Ding W.D.; Lang S.A.; Rossi M.; Bloom J.D.; Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: A new class of heterocycles with flavin-like redox properties. Bioorg Med Chem Lett 2003,13,3483-3486","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.bmc.2011.02.007","volume":"19","author":"Jordao A.K.","year":"2011","unstructured":"Jordao A.K.; Ferreira V.F.; Souza T.M.L.; de Souza F.G.G.; Machado V.; Abrantes J.L.; de Souza M.C.B.V.; Cunha A.C.; Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives. Bioorg Med Chem 2011,19,1860-1865","journal-title":"Bioorg Med Chem"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1016\/j.ejmech.2009.04.046","volume":"44","author":"Jordao A.K.","year":"2009","unstructured":"Jordao A.K.; Afonso P.P.; Ferreira V.F.; de Souza M.C.B.V.; Almeida M.C.B.; Beltrame C.O.; Paiva D.P.; Wardell S.M.S.V.; Wardell J.L.; Tiekink E.R.T.; Damaso C.R.; Cunha A.C.; Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture. Eur J Med Chem 2009,44,3777-3783","journal-title":"Eur J Med Chem"},{"key":"ref=21","first-page":"453","volume":"13","author":"Wen Y-N.","year":"2017","unstructured":"Wen Y-N.; Zhang Z-F.; Liu N-N.; Andrei G.; Snoeck R.; Xiang Y-H.; Schols D.; Chen X.; Zhang Z-Y.; Zhang Q-S.; Wu Q-P.; Synthesis and antiviral activity of 5-(benzylthio)-4- carbamyl-1,2,3-triazoles against human cytomegalovirus (CMV) and varicella-zoster virus (VZV). Med Chem 2017,13,453-464","journal-title":"Med Chem"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15257770.2015.1115523","volume":"35","author":"Wen Y-N.","year":"2016","unstructured":"Wen Y-N.; Zhang Z-F.; Liu N-N.; Xiang Y-H.; Zhang Z-Y.; Andrei G.; Snoeck R.; Schols D.; Zhang Q-S.; Wu Q-P.; Synthesis and bioactivity of novel trisubstituted triazole nucleosides. Nucleosid Nucleotid Nucl Acid 2016,35,147-160","journal-title":"Nucleosid Nucleotid Nucl Acid"},{"key":"ref=23","first-page":"18","volume":"26","author":"Wen Y.","year":"2016","unstructured":"Wen Y.; Yuan W.; Wu Y.; Chen X.; Xiang Y.; Zhang Zh.; Liu N.; Andrei G.; Snoeck R.; Schols D.; Wu Q.; Synthesis and antiviral activity of 1,2,3-triazoles. Chin J Med Chem 2016,26,18-24","journal-title":"Chin J Med Chem"},{"key":"ref=24","first-page":"348","volume":"25","author":"Wen Y.","year":"2015","unstructured":"Wen Y.; Liu N.; Zhang Z.; Chen X.; Yuan W.; Zhang Q.; Wu Q.; Synthesis and antitumor activity of multisubstituted triazole derivatives. Chin J Med Chem 2015,25,348-354","journal-title":"Chin J Med Chem"},{"key":"ref=25","first-page":"41","volume":"24","author":"Gomes A.T.P.C.","year":"2013","unstructured":"Gomes A.T.P.C.; Martins P.R.C.; Rocha D.R.; Neves M.G.P.M.S.; Ferreira V.F.; Silva A.M.S.; Cavaleiro J.A.S.; da Silva F.D.C.; Consecutive tandem cycloaddition between nitriles and azides; synthesis of 5-amino-1H-[1, 2, 3]-triazoles. Synlett 2013,24,41-44","journal-title":"Synlett"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1039\/c2ob06852d","volume":"10","author":"Dieudonne-Vatran A.","year":"2012","unstructured":"Dieudonne-Vatran A.; Azoulay M.; Florent J-C.; A new access to 3-substituted-1(2H) -isoquinolone by tandem palladium-catalyzed intramolecular aminocarbonylation annulation. Org Biomol Chem 2012,10,2683-2691","journal-title":"Org Biomol Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/167189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T13:53:23Z","timestamp":1573394003000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/167189\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406414666181109095239","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}